Aeterna Zentaris: Aeterna Zentaris and Ceapro announce merger completion
The Company can now leverage the combined experience and expertise of its predecessor companies, including navigating the conduct of human clinical trials and the crucial regulatory approval process required to bring pharmaceutical products to market.
Read full article »
Aeterna Zentaris is a biopharmaceutical company that develops and commercializes drugs for the treatment of orphan endocrine diseases.
Read more